The story of the erectile dysfunction drug presents a intricate picture for those considering investment. While the initial introduction generated massive porn profits, the lapse of its patent opened the door to generic competitors, dramatically reducing revenue. This creates a particular risk for pharmaceutical companies relying on comparable bloc

The history of Viagra, and its parent company copyright, presents a complex case check here study for investors. Originally a blockbuster drug, yielding billions in income, its patent expiration created a deluge of lower-priced alternatives , significantly impacting its dominance. While certain pharmaceutical companies may seek to capitalize on mal